Treatment Breaks for Super Responders: An Update from the GUIDE Study of Guselkumab in Psoriasis

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Journal Scan of Three Trials for an Rx Option
Journal Scan of Three Trials for an Rx Option
Psoriasis
Journal Scan of Three Trials for an Rx Option
- Linda Stein Gold, MD
IFPA World PsO and PsA Conference
IFPA World PsO and PsA Conference
Psoriasis
IFPA World PsO and PsA Conference
- Wilson Liao, MD
In The Pipeline: Phase 1, 2, and 3
In The Pipeline: Phase 1, 2, and 3
Psoriasis
In The Pipeline: Phase 1, 2, and 3
The Latest on Systemic Agents for Psoriasis: A Q&A With Jashin J. Wu, MD, FAAD
The Latest on Systemic Agents for Psoriasis: A Q&A With Jashin J. Wu, MD, FAAD
Psoriasis
The Latest on Systemic Agents for Psoriasis: A Q&A With Jashin J. Wu, MD, FAAD
- Jashin J. Wu, MD, FAAD